AstraZeneca Partners with CSPC Pharmaceuticals to Identify and Develop Small Molecule Across Chronic Indications

Shots: AstraZeneca & CSPC have partnered to discover & develop pre-clinical candidates for multiple targets across chronic diseases, incl. a pre-clinical oral small molecule for immunological diseases As per the deal, CSPC will receive $110M upfront as well as ~$1.62B in development & ~$3.6B in sales milestones with net sales-based single digit royalties, while AstraZeneca…

ByRidhi RastogiJune 16, 2025

Enhancing Diagnostic Care: Richard Watts from Qiagen in a Stimulating Conversation with PharmaShots

Shots: Recently, Qiagen entered into a collaboration agreement with AstraZeneca to develop companion diagnostics for chronic diseases using Qiagen’s QIAstat-Dx system Today, at PharmaShots, we are joined by Richard Watts from Qiagen, who sheds light on their collaboration agreements with AstraZeneca and Eli Lilly, leveraging their syndromic testing platform, QIAstat-Dx Qiagen has partnered with over…

BySaurabh ChaubeyNovember 27, 2024

How Lifestyle Changes Can Improve Men’s Health as They Age: Key Strategies for Vitality

Aging is a natural part of life, but it doesn't mean giving up on good health and vitality. Many men worry about heart disease and other chronic diseases as they get older, but there are ways to tackle these concerns. Making small lifestyle changes can significantly improve men’s health as they age, leading to a…

ByEvans JamesOctober 21, 2024

AstraZeneca Partners with CSPC Pharmaceuticals to Identify and Develop Small Molecule Across Chronic Indications

Enhancing Diagnostic Care: Richard Watts from Qiagen in a Stimulating Conversation with PharmaShots

How Lifestyle Changes Can Improve Men’s Health as They Age: Key Strategies for Vitality

Contact US

OUR INFORMATION

FOLLOW US